Across TCGA pan-cancer cohorts, NEFMP1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated NEFMP1 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher NEFMP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NEFMP1 expression acts as an unfavorable survival marker, although some lineages such as GBM and LGG show a favorable association.
KICH, ESCA, and KIRC are the cancer types where NEFMP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.